Vidac Pharma Holding Plc (HAM:T9G)

Germany flag Germany · Delayed Price · Currency is EUR
0.5020
-0.0180 (-3.46%)
At close: Oct 1, 2025
-3.46%
Market Cap25.92M
Revenuen/a
Net Incomen/a
Shares Out51.63M
EPSn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,200
Average Volume3,051
Open0.5020
Previous Close0.5200
Day's Range0.5020 - 0.5020
52-Week Range0.3000 - 0.7900
Beta-0.36
RSI47.36
Earnings Daten/a

About Vidac Pharma Holding

Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases. The company is developing VDA-1102 ointment, an anti-neoplastic agent that is in Phase 2 clinical trials for triggering apoptosis in cancer cells with minimal effects on surrounding normal cells. It is also developing VDA-1102 IV, an anti-neoplastic agent; and VDA-1275, a potent small molecule new chemical entity that are in preclinical stage for use in the treatment of solid tumors. The company... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2021
Country United Kingdom
Stock Exchange Hamburg Stock Exchange
Ticker Symbol T9G
Full Company Profile

News

There is no news available yet.